Kevin Smart

Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: A double-blind randomized controlled trial

Saifudin Khalid, Robert Murdoch, Amy Newlands et al. · Journal of Allergy and Clinical Immunology · 2014 · 187 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

First-in-Human Phase I Study of Single-agent Vanucizumab, A First-in-Class Bispecific Anti-Angiopoietin-2/Anti-VEGF-A Antibody, in Adult Patients with Advanced Solid Tumors

Manuel Hidalgo, Maria Martinez‐García, Christophe Le Tourneau et al. · Clinical Cancer Research · 2017 · 102 citations

Medicine, Oncology, Pharmacology +17

The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjects

Bruce E. Miller, Sunil Mistry, Kevin Smart et al. · BMC Pharmacology and Toxicology · 2015 · 64 citations · Full text

Medicine, Clinical Pharmacokinetics, Pharmacology +16

The effects of a TRPV1 antagonist, SB-705498, in the treatment of seasonal allergic rhinitis

Philippe Bareille, Robert Murdoch, Jane Denyer et al. · International Journal of Clinical Pharmacology and Therapeutics · 2013 · 42 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Inhibition of capsaicin‐driven nasal hyper‐reactivity by <scp>SB</scp>‐705498, a <scp>TRPV</scp>1 antagonist

Carlijn Holland, Cornelis M. van Drunen, Jane Denyer et al. · British Journal of Clinical Pharmacology · 2013 · 32 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12